Do Opioids Lower Libido in Men?
Long-term opioid use is associated with reduced sex hormone levels and low libido in some men, but opioid exposure alone does not establish the cause of an individual’s reduced desire. The FDA recognises this risk and advises reporting sexual symptoms to the prescriber. [1]
How do opioids affect hormones relevant to male libido?
Opioids suppress the hypothalamic–pituitary–gonadal axis, the signalling system that regulates testosterone production. Opioid-induced androgen deficiency, or OPIAD, describes androgen deficiency associated with opioid use. Low libido is a symptom requiring assessment rather than proof of OPIAD. [2]
The FDA notes limitations in hormone studies: underlying illness, physical or psychological stressors and other medicines complicate causal interpretation. A clinician therefore reviews the prescription and the patient’s broader health rather than diagnosing from a medication name. [1]
How common is low libido during opioid treatment?
The opioid studies cited here do not establish a single population percentage for libido loss. Studies reporting androgen deficiency measure hormone outcomes, which are not equivalent to reduced desire. A prevalence estimate needs its population, hormone definition and sexual outcome specified.
A retrospective cohort included 1,585 men receiving stable opioid doses. Androgen deficiency occurred in 57% of long-acting users versus 35% of short-acting users. The adjusted odds ratio was 3.39, with a 95% confidence interval of 2.39–4.77. [3]
These percentages describe hormone findings in that selected cohort, not libido loss in 57% or 35% of all users. The observational design identifies an association; it does not prove that changing formulations restores sexual interest.
What evidence supports treatment of opioid-associated low libido?
A testosterone trial improved sexual desire in men with opioid-induced androgen deficiency; this selected population does not represent every opioid user with low libido. [2]
| Trial feature | Reported detail | Interpretation for libido |
|---|---|---|
| Population | Men aged 18–64 years taking opioid analgesics; total testosterone below 350 ng/dL | Results concern a selected hormone-deficient group. |
| Design | Randomised placebo-controlled testosterone gel trial; 14 weeks | Treatment was compared with placebo. |
| Follow-up | 84 randomised; 65 with efficacy follow-up data | Incomplete follow-up limits certainty. |
| Sexual outcome | Greater improvement in sexual desire with testosterone | Desire was measured directly. |
| Clinical pain outcome | No between-group difference in change in self-reported pain | Improved desire does not establish improved everyday pain. |
The testosterone threshold describes trial eligibility. The study does not establish long-term outcomes.
How is low libido assessed in men taking opioids?
Low libido assessment during opioid treatment begins with the symptom history and a medication review, followed by indicated hormone testing. Testosterone testing uses morning fasting samples in symptomatic men; a low result requires confirmation because levels vary between days. [4]
- Identify the exposure: Bring opioid names, doses, formulations, treatment duration and prescribing reasons.
- Record the timing: Describe when sexual interest changed relative to treatment and dose changes.
- Separate sexual symptoms: Distinguish low interest from erection, orgasm or ejaculation problems.
- Describe the context: Include pain, mood, sleep and other health changes.
- List other medicines: Include nonprescription products, alcohol and sedating medicines.
A record of symptoms helps the consultation; it does not prove the prescription caused them. For a distinction between erection difficulty and reduced desire, read ED and low libido in men.
Should men stop opioids to restore libido?
Men should not abruptly stop or rapidly reduce prescribed opioids to address libido concerns. The FDA warns that abrupt discontinuation in physically dependent patients has caused serious withdrawal, uncontrolled pain and other harm. Any change requires a clinician-led plan. [5]
Discuss the benefits and adverse effects of the current treatment with the prescriber. Pain management sometimes combines several approaches. The appropriate plan depends on the condition being treated and the patient’s response; an online ranking of opioids is not a personalised treatment plan. [5]
Track desire separately from pain and erection function during follow-up. A better hormone value, a lower dose or improved pain control does not automatically establish restored libido.
Which opioid symptoms require urgent care during a libido review?
Opioid-related breathing problems require emergency care even when the original concern is low libido. Seek urgent help for slow or difficult breathing, extreme sleepiness or inability to wake. These symptoms are different from an isolated change in sexual interest. [5]
Combining opioids with alcohol, benzodiazepines or other central nervous system depressants increases overdose risk. Discuss access to an opioid overdose reversal medicine, such as naloxone, with the treating clinician. [5]
References for opioids and male libido
These opioid and libido sources distinguish androgen deficiency, measured sexual desire and medication safety. Hormone prevalence estimates are not presented as libido-loss rates.
- FDA: Safety communication on opioid medicines and endocrine risks, March 2016.
- Basaria et al. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomised controlled trial. 2015.
- Rubinstein and Carpenter. Risk factors for androgen deficiency associated with daily opioid use. 2014.
- Society for Endocrinology and Association of Clinical Biochemistry and Laboratory Medicine: Biochemical confirmation of adult male hypogonadism. 2023.
- FDA: Updated prescribing information regarding long-term opioid use, July 2025.
